This year should produce further robust deal activity in global healthcare, but acquisition multiples may come down to finance the higher cost of debt, according to Bain & Company Partner Nirad Jain. Jain, who co-authors the firm's Global Healthcare Private Equity Report., thinks a reduction in multiples "may not be a terrible thing" as multiples have been rising slowly over the past few years, propelled partly by cheap financing.